KDM2A and Alzheimer disease: Importantly, we found equal dependency on KDM2A in AD and SCLC cell lines, highlighting the importance of this gene and suggesting the possibility to also develop a targeted therapy approach for SCLC patients, whose therapeutic options are still very limited.